The programme of the Symposium will include plenary lectures given by the most esteemed international experts from different PET disciplines. Free papers are welcome for oral and poster presentations during the meeting. In addition, the Symposium programme will include parallel workshops and user meetings.
Turku PET Symposium 2025 | 6-9 June 2025 | Turku, Finland
Programme
15:00–16:00 |
Turku PET Centre Site Visit, Group 1 |
16:00–17:00 |
Registration opens at the symposium venue, Turku City Theatre |
17:00 |
Get-together, Turku City Theatre |
8:00 |
Registration |
8:30–10:15 |
Radiochemistry (The Little Stage) |
| 8:30–9:00 | Imaging DNA damage and radionuclide therapy Bart Cornelissen, University of Groningen/Oxford University, The Netherlands/United Kingdom |
| 9:00–9:30 | Radiochemical syntheses of 18F- and 11C- labeled aminopyridines for brain imaging of demyelination Pedro Brugarolas, Gordon Center for Medical Imaging of Massachusetts General Hospital and Harvard Medical School, United States |
| 9:30–9:45 | [11C]Sotagliflozin towards personalized approach in SGLT1/2 inhibitors Emma Baglini, National Research Council of Italy, Italy |
| 9:45–10:00 | Radiolabeling of nitrosoarenes with [18F]fluoride Markus Laube, Helmholtz-Zentrum Dresden, Germany |
| 10:00–10:15 | Star poly(2-oxazoline) polymer for prostate-specific membrane antigen (PSMA) therapy Alessia Centanni, University of Helsinki, Finland |
10:15-10:45 |
Coffee & exhibition |
10:45–12:30 |
Preclinical imaging (The Little Stage) |
| 10:45–11:15 | Imaging inflammation and active fibrosis in multiple organs with Positron Emission Tomography Adriana Tavares, University of Edinburgh, United Kingdom |
| 11:15–11:45 | PET in cell replacement therapy for diabetes Väinö Lithovius, Helmholtz Munich, Germany |
| 11:45–12:00 | Novel theranostic agent targeting tumor stroma Mengfei Xiong, Uppsala University, Sweden |
| 12:00–12:15 | Radioactive flow cytometry and magnetic cell sorting (radioflow/radiomag): two new approaches to investigate radiotracer uptake on single-cell level Chrysoula Vraka, Medical University of Vienna, Austria |
| 12:15–12:30 | [18F]Niacin for PET imaging glioblastoma via monocarboxylate transporter 1 mediated blood-brain barrier penetration Pyry Dillemuth, Turku PET Centre, Finland |
12:30-13:30 |
Lunch & exhibition |
13:15–14:30 |
Poster session I |
|
|
Radiochemistry, Preclinical imaging, Instrumentation, Total-body PET |
14:00-14:30 |
Coffee & exhibition |
14:30–16:00 |
Instrumentation (The Little Stage) |
| 14:30–15:00 | ENHANCE.PET: Past, Present and Future Lalith Kumar Shiyam Sundar, Medical University of Vienna, Austria |
| 15:00–15:30 | Biological Multiplexing with PET: Methods to interrogate multiple disease biomarkers in a single PET imaging session Craig S. Levin, Stanford University, United States |
| 15:30–15:45 | AttUNet DL-based Method for Positron Range Correction in Clinical PET Imaging Nerea Encina Baranda, Universidad Complutense de Madrid, Spain |
| 15:45–16:00 | Automated total-body PET image processing and kinetic modelling with the turbo toolbox Jouni Tuisku, Turku PET Centre, Finland |
16:00–17:15 |
Early-career researchers’ session (The Little Stage) |
| 16:00–16:25 | My clinical academic path in cardiovascular research and molecular imaging Jason Tarkin, University of Cambridge, United Kingdom |
| 16:25–16:50 | An academic journey in metabolism: How PET became my career partner Guillermo Sánchez Delgado, Universidad de Granada, Spain |
| 16:50–17:15 | Career choices of a PET researcher: From academia to industry Iina Laitinen, Antaros Medical, Sweden |
18:30 |
Cultural experience |
08:00 |
Registration |
8:30–10:30 |
Neuroimaging & Emotions (The Little Stage) |
| 8:30–9:15 | The self-regulation of pain and emotion: A view from neuroimaging Tor D. Wager, Dartmouth College, United States |
| 9:15–10:00 | Pharmacology of the glymphatic system: implications for CNS clearance and drug delivery Tuomas Lilius, University of Helsinki, Finland |
| 10:00–10:15 | Neural and metabolic correlates of emotion processing: insights from fPET fMRI Vesa Putkinen, Turku PET Centre, Finland |
| 10:15–10:30 | Tracking neurodegenerative disease progression in isolated REM-sleep behavior disorder using brain 18F-FDG PET Sofie Lövdal, University of Groningen, The Netherlands |
10:30-11:00 |
Coffee & exhibition |
11:00–13:00 |
Molecular imaging in cardiovascular diseases (The Little Stage) |
| 11:00–11:30 | Brave New World: Molecular Theragnostic Pairs in Cardiovascular Disease James Thackeray, Hannover Medical School, Germany |
| 11:30–12:00 | The future of clinical nuclear cardiology Frank Bengel, Medizinische Hochschule Hannover, Germany |
| 12:00–12:30 | Total body perfusion in patients with chest pain Juhani Knuuti, Turku PET Centre, Finland |
| 12:30–12:45 | Evaluation of Gd-DOTA as a marker for myocardial blood flow using 68Ga-DOTA and 15O-water PET Tanja Kero, Uppsala University, Sweden |
| 12:45–13:00 | Long axial field of view PET/CT with [15O]O2 and [15O]H2O in patients under anaesthesia Nanna Elgaard Toft and Leonora Rojek Simonsen, Aarhus Universitetshospital, Denmark |
13:00-14:00 |
Lunch & exhibition |
13:45–14:45 |
Poster session II |
|
|
Neuroimaging, Cardiology, Cancer imaging, Metabolism |
14:45-15:15 |
Coffee & exhibition |
15:15–17:30 |
PET Radiochemistry 50th anniversary (The Little Stage) |
| 15:15–15:30 | Opening Anu Airaksinen, Turku PET Centre, Finland |
| 15:45–16:15 | 50 Years of Radiochemistry in Turku Olof Solin, Turku PET Centre, Finland |
| 16:15–17:00 | Creating the Future of Neuroinflammation PET Imaging Michelle L. James, Stanford University School of Medicine, United States |
| 17:00–17:30 | Gadolin lecture |
19:00 |
Congress banquet |
08:00 |
Registration |
8:30–10:30 |
Cancer imaging (The Little Stage) |
| 8:30–9:00 | AI in cancer PET imaging analysis Elin Trägårdh, Lund University, Sweden |
| 9:00–9:30 | Prospects of Clinical Alpha Therapy Kalevi Kairemo, Finland |
| 09:30–09:45 | The Artificial study nurse for auditable cognitive information extraction from PET reports George Prenosil, Bern University Hospital, CH |
| 09:45-10:00 | Tezatabep matraxetan for PET imaging of HER2-expressing cancers Guido Würth, Affibody AB, Sweden |
| 10:00-10:15 | There and back again: in vitro challenges of small molecule PD-L1 radioligand development Cornelius Donat, Institute of Radiopharmaceutical Cancer Research, HZDR, Germany |
| 10:15-10:30 | Parametric analysis of dynamic long axial field-of-view 18F-FDG PET/CT studies Charlotte Smith, Amsterdam UMC, The Netherlands |
10:30-11:00 |
Coffee & exhibition |
11:00–13:00 |
Metabolism (The Little Stage) |
| 11:00–11:45 | PET-imaging of gut microbiota and its metabolic interaction Patricia Iozzo, National Research Council (CNR), Pisa, Italy |
| 11:45–12:30 | The effects of exercise on whole body beyond skeletal muscle Jarna Hannukainen, Turku PET Centre, Finland |
| 12:30–12:45 | Challenges in simultaneous quantitative imaging of regional blood flow in total-body organs Iida Hidehiro, Turku PET Centre, Finland |
| 12:45–13:00 | Translational imaging of pancreatic β-cells in individuals with type 1 and type 2 diabetes and obesity, using the PET tracer [68Ga]Ga-NODAGA-exendin-4 Silvia Migliari, University of Parma, Italy |
13:00–13:20 |
Closing of the symposium (The Little Stage) |
|
|
Juhani Knuuti – Chairman of the Organising Committee |
13:30–15:00 |
Turku PET Centre Site Visit, Group 2 |
